Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN:US

163.5800 USD 3.2900 1.97%

As of 20:10:00 ET on 04/17/2015.

Company Profile for Amgen Inc (AMGN)

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Contact Information

Amgen Inc

One Amgen Center Drive
Building 27
Thousand Oaks, CA 91320-1799
United States
Phone: 1-805-447-1000
Fax: 1-805-447-1010

Key Executives for Amgen Inc (AMGN)

Robert A Bradway "Bob"Chairman/President/CEOAnnette L SuchChief Accounting Officer
David W MelineExec VP/CFOAnthony C Hooper "Tony"Exec VP:Global Commercial Ops
Brian M McNameeExec VP:Full PotentialMadhavan Balachandran "Madhu"Exec VP:Operations
Sean E HarperExec VP:Research & DevDavid J ScottSenior VP/Secy/General Counsel
Mary A LehmannVP:Finance & TreasurerArvind SoodVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil